DENVER, April 12,
2023 /PRNewswire/ --
ViewRay, Inc. (NASDAQ: VRAY) will hold a conference call to discuss
results on Thursday, April
13, 2023, at 8:00
AM ET. The dial-in number for domestic
callers is (888) 886-7786. The confirmation number is
56031524. A live webcast of the conference call will be available
on the investor relations page of ViewRay's corporate website at
https://investors.viewray.com/events-and-webinars.
After the live webcast, a replay will remain available
online on the investor relations
page of ViewRay's
website under "Events and Webinars".
About ViewRay®
ViewRay, Inc.
(Nasdaq: VRAY) designs, manufactures, and markets the MRIdian® MR-Guided Radiation Therapy System.
MRIdian is built upon a proprietary high-definition
MR imaging system designed from the ground up to address the unique
challenges and clinical workflow for advanced
radiation oncology. Unlike MR systems
used in diagnostic radiology, MRIdian's high-definition MR was purpose-built to address specific
challenges,
including beam distortion, skin toxicity, and other concerns
that potentially may arise when high magnetic
fields interact with radiation beams. ViewRay
and MRIdian are registered trademarks of ViewRay, Inc.
View original
content:https://www.prnewswire.com/news-releases/viewray-announces-conference-call-for-preliminary-first-quarter-2023-financial-results-to-be-held-pre-market-opening-on-april-13-2023-301796074.html
SOURCE ViewRay, Inc.